Discovery of novel determinants of endothelial lineage using chimeric heterokaryons

  1. Wing Tak Wong
  2. Gianfranco Matrone
  3. XiaoYu Tian
  4. Simion Alin Tomoiaga
  5. Kin Fai Au
  6. Shu Meng
  7. Sayumi Yamazoe
  8. Daniel Sieveking
  9. Kaifu Chen
  10. David M Burns
  11. James K Chen
  12. Helen M Blau
  13. John P Cooke  Is a corresponding author
  1. Houston Methodist Research Institute, United States
  2. University of Iowa, United States
  3. Stanford University School of Medicine, United States

Abstract

We wish to identify determinants of endothelial lineage. Murine embryonic stem cells (mESC) were fused with human endothelial cells in stable, non-dividing, heterokaryons. Using RNA-seq it is possible to discriminate between human and mouse transcripts in these chimeric heterokaryons. We observed a temporal pattern of gene expression in the ESCs of the heterokaryons that recapitulated ontogeny, with early mesodermal factors being expressed before mature endothelial genes. A set of transcriptional factors not known to be involved in endothelial development was upregulated, one of which was POU class 3 homeobox 2 (Pou3f2). We confirmed its importance in differentiation to endothelial lineage via loss- and gain-of-function (LOF and GOF). Its role in vascular development was validated in zebrafish embryos using morpholino oligonucleotides. These studies provide a systematic and mechanistic approach for identifying key regulators in directed differentiation of pluripotent stem cells to somatic cell lineages.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Wing Tak Wong

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Gianfranco Matrone

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. XiaoYu Tian

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Simion Alin Tomoiaga

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Kin Fai Au

    Department of Internal Medicine, University of Iowa, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Shu Meng

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Sayumi Yamazoe

    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Daniel Sieveking

    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Kaifu Chen

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. David M Burns

    Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. James K Chen

    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Helen M Blau

    Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. John P Cooke

    Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, United States
    For correspondence
    jpcooke@houstonmethodist.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0033-9138

Funding

National Institutes of Health

  • John P Cooke

American Heart Association

  • Wing Tak Wong

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Gordana Vunjak-Novakovic, Columbia University, United States

Ethics

Animal experimentation: Zebrafish are kept according to the laboratory protocols described in Zebrafish: A Practical Approach (Oxford University Press, 2002). These protocols comply with the Guide for the Care and Use of Laboratory Animals, the American Association for the Accreditation of Laboratory Animal Care (AAALAC) standards, and the regulations set forth in the Animals Welfare Act (P.L. 89-544, as amended by P.L. 91-579 and P.L . 94-279). Veterinary care is provided on a 24 hours basis, including weekends and holidays, by a staff of veterinarians with specialties in laboratory animal medicine and anesthesiology, and licensed animal health technicians. Training classes are offered. All veterinary care is provided by Houston Methodist Research Institute, which is fully accredited by AAALAC (ID A4555-01) and holds an approved NIH Assurance and USDA License (start date 03/08/2013). Support includes quarantine rooms, sterile operating rooms, post-surgical recovery rooms, radiology and diagnostic laboratory services. All surgery procedures were performed under anesthesia with Tricaine 0.02 mg/ml.

Version history

  1. Received: November 23, 2016
  2. Accepted: March 17, 2017
  3. Accepted Manuscript published: March 21, 2017 (version 1)
  4. Version of Record published: April 13, 2017 (version 2)
  5. Version of Record updated: April 24, 2017 (version 3)

Copyright

© 2017, Wong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,432
    views
  • 248
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wing Tak Wong
  2. Gianfranco Matrone
  3. XiaoYu Tian
  4. Simion Alin Tomoiaga
  5. Kin Fai Au
  6. Shu Meng
  7. Sayumi Yamazoe
  8. Daniel Sieveking
  9. Kaifu Chen
  10. David M Burns
  11. James K Chen
  12. Helen M Blau
  13. John P Cooke
(2017)
Discovery of novel determinants of endothelial lineage using chimeric heterokaryons
eLife 6:e23588.
https://doi.org/10.7554/eLife.23588

Share this article

https://doi.org/10.7554/eLife.23588

Further reading

    1. Cell Biology
    Ruichen Yang, Hongshang Chu ... Baojie Li
    Research Article

    Elastic cartilage constitutes a major component of the external ear, which functions to guide sound to the middle and inner ears. Defects in auricle development cause congenital microtia, which affects hearing and appearance in patients. Mutations in several genes have been implicated in microtia development, yet, the pathogenesis of this disorder remains incompletely understood. Here, we show that Prrx1 genetically marks auricular chondrocytes in adult mice. Interestingly, BMP-Smad1/5/9 signaling in chondrocytes is increasingly activated from the proximal to distal segments of the ear, which is associated with a decrease in chondrocyte regenerative activity. Ablation of Bmpr1a in auricular chondrocytes led to chondrocyte atrophy and microtia development at the distal part. Transcriptome analysis revealed that Bmpr1a deficiency caused a switch from the chondrogenic program to the osteogenic program, accompanied by enhanced protein kinase A activation, likely through increased expression of Adcy5/8. Inhibition of PKA blocked chondrocyte-to-osteoblast transformation and microtia development. Moreover, analysis of single-cell RNA-seq of human microtia samples uncovered enriched gene expression in the PKA pathway and chondrocyte-to-osteoblast transformation process. These findings suggest that auricle cartilage is actively maintained by BMP signaling, which maintains chondrocyte identity by suppressing osteogenic differentiation.

    1. Cancer Biology
    2. Cell Biology
    Timothy J Walker, Eduardo Reyes-Alvarez ... Lois M Mulligan
    Research Article

    Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be caused by activating mutations of the rearranged during transfection (RET) receptor tyrosine kinase, or inactivation of TMEM127, a transmembrane tumor suppressor implicated in trafficking of endosomal cargos. However, the role of aberrant receptor trafficking in PCC is not well understood. Here, we show that loss of TMEM127 causes wildtype RET protein accumulation on the cell surface, where increased receptor density facilitates constitutive ligand-independent activity and downstream signaling, driving cell proliferation. Loss of TMEM127 altered normal cell membrane organization and recruitment and stabilization of membrane protein complexes, impaired assembly, and maturation of clathrin-coated pits, and reduced internalization and degradation of cell surface RET. In addition to RTKs, TMEM127 depletion also promoted surface accumulation of several other transmembrane proteins, suggesting it may cause global defects in surface protein activity and function. Together, our data identify TMEM127 as an important determinant of membrane organization including membrane protein diffusability and protein complex assembly and provide a novel paradigm for oncogenesis in PCC where altered membrane dynamics promotes cell surface accumulation and constitutive activity of growth factor receptors to drive aberrant signaling and promote transformation.